Occupe actuellement des postes chez PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | PTC Therapeutics Inc | 13 juin 2016 - |
Independent Director | Xenon Pharmaceuticals Inc | 27 septembre 2016 - |
Independent Director | Global Blood Therapeutics Inc | 19 décembre 2018 - |
Director | Endocyte Inc | None - |
Independent Director | Medivation Inc | 1 décembre 2014 - 28 septembre 2016 |
Interim Chief Commercial Officer, Director | Medivation Inc | 10 juillet 2014 - 1 décembre 2014 |
Independent Director | Medivation Inc | 1 avril 2013 - 10 juillet 2014 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-08-24 | 2023-08-24 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Vente |
25 000
-50.0%
38,70967 500 USD |
25 000 -50.0% | 38,70 | 967 500 USD | |
2023-05-11 | 2023-05-09 |
ACELYRIN Inc
(SLRN)
|
A Achat |
15 000
+inf%
18,00270 000 USD |
15 000 +inf% | 18,00 | 270 000 USD | |
2022-06-22 | 2022-06-21 | VP Vente planifiée |
1 908
-26.2%
27,2451 983 USD |
1 908 -26.2% | 27,24 | 51 983 USD | ||
2022-06-10 | 2022-06-09 |
PTC Therapeutics Inc
(PTCT)
|
V Vente |
738
-2.5%
27,2020 074 USD |
738 -2.5% | 27,20 | 20 074 USD | |
2022-05-18 | 2022-05-16 |
Adverum Biotechnologies Inc
(ADVM)
|
A Achat |
30 000
+150.0%
0,8525 578 USD |
30 000 +150.0% | 0,85 | 25 578 USD | |
2022-01-11 | 2022-01-07 |
PTC Therapeutics Inc
(PTCT)
|
V Vente |
510
-1.9%
38,5319 648 USD |
510 -1.9% | 38,53 | 19 648 USD | |
2021-06-21 | 2021-06-18 | VP Vente planifiée |
1 609
-30.4%
36,5458 793 USD |
1 609 -30.4% | 36,54 | 58 793 USD | ||
2021-06-11 | 2021-06-09 |
PTC Therapeutics Inc
(PTCT)
|
V Vente |
365
-1.3%
41,8915 288 USD |
365 -1.3% | 41,89 | 15 288 USD | |
2021-04-01 | 2021-03-31 |
Adverum Biotechnologies Inc
(ADVM)
|
A Achat |
20 000
+inf%
10,02200 338 USD |
20 000 +inf% | 10,02 | 200 338 USD | |
2021-02-02 | 2021-02-01 |
PTC Therapeutics Inc
(PTCT)
|
V Vente |
506
-1.8%
56,9628 820 USD |
506 -1.8% | 56,96 | 28 820 USD | |
2020-06-19 | 2020-06-19 | VP Vente planifiée |
881
-28.1%
64,4256 750 USD |
881 -28.1% | 64,42 | 56 750 USD | ||
2020-06-19 | 2020-06-19 | VP Vente planifiée |
1 663
-34.6%
63,69105 913 USD |
1 663 -34.6% | 63,69 | 105 913 USD | ||
2020-06-12 | 2020-06-11 |
PTC Therapeutics Inc
(PTCT)
|
V Vente |
364
-1.4%
48,3617 603 USD |
364 -1.4% | 48,36 | 17 603 USD |